News

Filter By :

Category

  • All
  • AppleGate Recovery
  • BAART Programs
  • BayMark Health Services
  • Canadian Addiction Treatment Centres
  • Family Recovery Solutions
  • Granite Recovery
  • Health Care Resource Centers
  • Hope For Tomorrow
  • Liberty Bay Recovery Center
  • MedMark Treatment Centers
  • Middlesex Recovery
  • Mt. Sinai
  • Nashville Recovery Suboxone Clinic
  • New Day Recovery
  • Pathfinders Recovery Center
  • Recovery Pathways
  • Recovery Services of New Mexico
  • Riverwood Group
  • San Antonio Recovery Center
  • SpecialCare Hospital Management
  • The Coleman Institute
  • Uncategorized

Date Posted

2023 Opioid Use Disorder Treatment Outcomes Report

BayMark, a leading provider of medication-assisted treatment (MAT) for opioid use disorder (OUD), is thrilled to announce the release of its much-anticipated whitepaper, the "2023 Nationwide Opioid Use Disorder Treatment Outcomes Report". This comprehensive study, conducted with one of the largest-ever data sets in the field, delves deep into the efficacy of medication-assisted treatment (MAT). This detailed report, based on an exhaustive analysis of approximately 39,000 patients, offers a trove of knowledge and evidence-based clinical outcomes.

November 27th 2023
Get The Whitepaper

BayMark Announces Acquisition Of Opioid Treatment Program In Washington, D.C.

Mar 15th 2021

BayMark Health Services recently completed the acquisition of PIDARC (Partners in Drug Abuse Rehabilitation Counseling), a prominent medication-assisted treatment (MAT) in Washington, D.C.  The program provides treatment for opioid use disorder (OUD) offering high-quality, effective medication-assisted treatment (MAT) services with methadone supported by substance use counseling and linkages to a...

Read More

2023 Opioid Use Disorder Treatment Outcomes Report

BayMark, a leading provider of medication-assisted treatment (MAT) for opioid use disorder (OUD), is thrilled to announce the release of its much-anticipated whitepaper, the "2023 Nationwide Opioid Use Disorder Treatment Outcomes Report". This comprehensive study, conducted with one of the largest-ever data sets in the field, delves deep into the efficacy of medication-assisted treatment (MAT). This detailed report, based on an exhaustive analysis of approximately 39,000 patients, offers a trove of knowledge and evidence-based clinical outcomes.

November 27th 2023
Get The Whitepaper

BayMark Health Services Addiction Treatment Expands Into Western Tennessee

Feb 16th 2021

AppleGate Recovery, a BayMark Health Services company, announced the acquisition of Redemption Recovery, a group of five office-based opioid treatment (OBOT) programs based in Jackson, TN. Established in 2015, Redemption Recovery provides buprenorphine and Suboxone® medication-assisted treatment and counseling in a physician’s office setting. Redemption Recovery was established to offer...

Read More

2023 Opioid Use Disorder Treatment Outcomes Report

BayMark, a leading provider of medication-assisted treatment (MAT) for opioid use disorder (OUD), is thrilled to announce the release of its much-anticipated whitepaper, the "2023 Nationwide Opioid Use Disorder Treatment Outcomes Report". This comprehensive study, conducted with one of the largest-ever data sets in the field, delves deep into the efficacy of medication-assisted treatment (MAT). This detailed report, based on an exhaustive analysis of approximately 39,000 patients, offers a trove of knowledge and evidence-based clinical outcomes.

November 27th 2023
Get The Whitepaper

BayMark Health Services Acquires Pennsylvania Opioid Treatment Program

Dec 18th 2020

BayMark Health Services announced the acquisition of Echo Treatment Center, an opioid treatment provider in Washington, Pennsylvania. Echo Treatment provides outpatient medication-assisted treatment (MAT) utilizing methadone and substance abuse counseling and education. The facility will fall under BayMark’s MedMark Treatment Centers brand. Providing a broad continuum of care for the...

Read More

2023 Opioid Use Disorder Treatment Outcomes Report

BayMark, a leading provider of medication-assisted treatment (MAT) for opioid use disorder (OUD), is thrilled to announce the release of its much-anticipated whitepaper, the "2023 Nationwide Opioid Use Disorder Treatment Outcomes Report". This comprehensive study, conducted with one of the largest-ever data sets in the field, delves deep into the efficacy of medication-assisted treatment (MAT). This detailed report, based on an exhaustive analysis of approximately 39,000 patients, offers a trove of knowledge and evidence-based clinical outcomes.

November 27th 2023
Get The Whitepaper

BayMark Health Services Partners With Pennsylvania Suboxone Provider Group

Dec 17th 2020

BayMark Health Services recently announced their partnership with Recovery Pathways, an office-based opioid treatment (OBOT) provider with three locations in Western Pennsylvania. The programs, two of which are located in Washington, PA and the third in Monroeville, PA, offer medication-assisted treatment (MAT) for opioid addiction using buprenorphine-based medications in an...

Read More

2023 Opioid Use Disorder Treatment Outcomes Report

BayMark, a leading provider of medication-assisted treatment (MAT) for opioid use disorder (OUD), is thrilled to announce the release of its much-anticipated whitepaper, the "2023 Nationwide Opioid Use Disorder Treatment Outcomes Report". This comprehensive study, conducted with one of the largest-ever data sets in the field, delves deep into the efficacy of medication-assisted treatment (MAT). This detailed report, based on an exhaustive analysis of approximately 39,000 patients, offers a trove of knowledge and evidence-based clinical outcomes.

November 27th 2023
Get The Whitepaper

BayMark Announces Acquisition of Three Opioid Treatment Programs in Louisiana

Dec 16th 2020

BayMark Health Services has acquired Choices of Louisiana, an Opioid Treatment company consisting of three Opioid Treatment Programs (OTPs), one in Alexandria and two in the New Orleans, LA market. The programs provide medication-assisted treatment (MAT) for opioid addiction supported by substance use counseling. For more than 20 years, Choices...

Read More

2023 Opioid Use Disorder Treatment Outcomes Report

BayMark, a leading provider of medication-assisted treatment (MAT) for opioid use disorder (OUD), is thrilled to announce the release of its much-anticipated whitepaper, the "2023 Nationwide Opioid Use Disorder Treatment Outcomes Report". This comprehensive study, conducted with one of the largest-ever data sets in the field, delves deep into the efficacy of medication-assisted treatment (MAT). This detailed report, based on an exhaustive analysis of approximately 39,000 patients, offers a trove of knowledge and evidence-based clinical outcomes.

November 27th 2023
Get The Whitepaper

2023 Opioid Use Disorder Treatment Outcomes Report

BayMark, a leading provider of medication-assisted treatment (MAT) for opioid use disorder (OUD), is thrilled to announce the release of its much-anticipated whitepaper, the "2023 Nationwide Opioid Use Disorder Treatment Outcomes Report". This comprehensive study, conducted with one of the largest-ever data sets in the field, delves deep into the efficacy of medication-assisted treatment (MAT). This detailed report, based on an exhaustive analysis of approximately 39,000 patients, offers a trove of knowledge and evidence-based clinical outcomes.

November 27th 2023
Get The Whitepaper

BayMark Health Services Acquires Indiana Opioid Treatment Programs

Nov 18th 2020

BayMark Health Services has announced the acquisition of Limestone Health, an opioid treatment provider with locations in Bloomington and Lafayette, Indiana, formerly owned by Springstone, Inc. Limestone provides outpatient medication-assisted treatment (MAT) with methadone services including medication management and substance abuse counseling and education. The programs will fall under BayMark’s...

Read More

2023 Opioid Use Disorder Treatment Outcomes Report

BayMark, a leading provider of medication-assisted treatment (MAT) for opioid use disorder (OUD), is thrilled to announce the release of its much-anticipated whitepaper, the "2023 Nationwide Opioid Use Disorder Treatment Outcomes Report". This comprehensive study, conducted with one of the largest-ever data sets in the field, delves deep into the efficacy of medication-assisted treatment (MAT). This detailed report, based on an exhaustive analysis of approximately 39,000 patients, offers a trove of knowledge and evidence-based clinical outcomes.

November 27th 2023
Get The Whitepaper

BayMark Health Services Opens New Opioid Treatment Program In Attleboro, Massachusetts

Jul 30th 2020

BayMark Health Services announced the opening of Health Care Resource Centers Attleboro (HCRC), its eleventh opioid treatment program in Massachusetts offering comprehensive medication-assisted treatment (MAT) with methadone. The clinic, located at 23 North Main Street in Attleboro is now accepting patients. In addition to treatment with methadone, HCRC Attleboro provides...

Read More
Now Available: BayMark's 2023 Treatment Outcomes ReportGet the Whitepaper